Valuation: GI Innovation, Inc.

Market Cap 506B 335M 293M 270M 250M 475M 31.98B 483M 3.24B 1.27B 15.7B 1.26B 1.23B 54.39B P/E 2024
-6.04x
P/E 2025 -29.2x
Enterprise Value 471B 312M 273M 252M 233M 442M 29.79B 450M 3.02B 1.18B 14.63B 1.17B 1.15B 50.67B EV / Sales 2024
15,970x
EV / Sales 2025 187x
Free-Float
93.28%
Yield 2024 *
-
Yield 2025 -
1 day-2.00%
1 week-15.70%
Current month-24.10%
1 month-32.41%
3 months-40.47%
6 months-50.94%
Current year-55.56%
1 week 7,700
Extreme 7700
9,320
1 month 7,700
Extreme 7700
15,230
Current year 7,700
Extreme 7700
18,830
1 year 7,700
Extreme 7700
22,600
3 years 6,809.09
Extreme 6809.0909
24,900
5 years 6,809.09
Extreme 6809.0909
24,900
10 years 6,809.09
Extreme 6809.0909
24,900
Manager TitleAgeSince
Chief Executive Officer 58 02/07/2025
Chief Executive Officer 54 16/06/2021
Director of Finance/CFO - 01/09/2024
Director TitleAgeSince
Director/Board Member 44 -
Director/Board Member 55 -
Director/Board Member 51 03/03/2022
Date Insider Type Main position Quantity % Market Cap.
01-20Expiration 11 0.0000%
01-20Fiscal year 11 0.0000%
01-20Fiscal year 899 0.0014%
Change 5-day change 1-year change 3-year change Capi.($)
-2.00%-15.70%-59.96%+3.65% 335M
+0.96%+2.44%+3.30%+11.28% 50.44B
+0.72%+1.00%+396.18%+624.25% 40.63B
+2.54%+0.93%+28.98%-3.62% 34.88B
+0.31%+1.74%+18.44%+59.76% 33.67B
-2.09%-1.98%+3.21%+33.56% 26.29B
-0.63%+0.34% - - 17.11B
+0.66%-3.96%+66.85%+127.36% 15.29B
-23.90%-21.43%+50.06%+53.83% 10.62B
+0.96%+0.14%+14.58%+21.99% 13.74B
Average -2.25%-3.72%+57.96%+103.56% 24.3B
Weighted average by Cap. -0.49%-0.62%+87.27%+139.55%

Financials

2024 2025
Net sales 24.28M 16.08K 14.07K 12.97K 12K 22.78K 1.54M 23.17K 155K 60.91K 754K 60.38K 59.07K 2.61M 5.84B 3.87M 3.38M 3.12M 2.89M 5.48M 369M 5.57M 37.36M 14.64M 181M 14.52M 14.2M 628M
Net income -58.78B -38.94M -34.06M -31.41M -29.06M -55.16M -3.72B -56.08M -376M -147M -1.83B -146M -143M -6.32B -35.13B -23.27M -20.36M -18.77M -17.37M -32.97M -2.22B -33.52M -225M -88.13M -1.09B -87.36M -85.47M -3.78B
Net Debt -3.44B -2.28M -1.99M -1.84M -1.7M -3.23M -217M -3.28M -22.01M -8.63M -107M -8.55M -8.37M -370M -34.63B -22.93M -20.06M -18.5M -17.12M -32.49M -2.19B -33.04M -222M -86.86M -1.08B -86.1M -84.24M -3.72B
Logo GI Innovation, Inc.
GI Innovation Inc is a Korea-based company engaged in the research and development of next-generation immunotherapies based on fusion proteins. The Company is engaged in the business of generating revenue through license fees by technology transfer of new drug candidates in pre-clinical and early clinical stages. The core new drug pipeline includes products such as GI-101 immuno-oncology and GI-301 allergy treatment.
Employees
-
Date Price Change Volume
09/07/26 ₩7,840.00 -2.00% 429,087
08/07/26 ₩8,000.00 -9.40% 1,112,896
07/07/26 ₩8,830.00 +2.20% 437,240
06/07/26 ₩8,640.00 -3.89% 403,536
03/07/26 ₩8,990.00 -3.33% 424,028
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
CCC
  1. Stock Market
  2. Stocks
  3. A358570 Stock